Summary for patients. An unusual "side effect" of an acne drug.
D000152:Acne Vulgaris / Q000097:blood / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D001057:Apolipoproteins E / Q000235:genetics; D001835:Body Weight; D003430:Cross-Sectional Studies; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D005951:Glucose Tolerance Test; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced* / Q000235:genetics*; D007328:Insulin / Q000097:blood; D015474:Isotretinoin / Q000009:adverse effects*; D008055:Lipids / Q000097:blood; D008297:Male; D024821:Metabolic Syndrome / Q000235:genetics*; D008875:Middle Aged; D010597:Pharmacogenetics; D012189:Retrospective Studies; D012307:Risk Factors
D001057:Apolipoproteins E; D003879:Dermatologic Agents; D007328:Insulin; D008055:Lipids; D015474:Isotretinoin